Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 58.8%
Negative

Positive
Seeking Alpha
12 days ago
Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves
Neogen Corporation's sizeable $11 billion food-and-animal safety TAM still has secular tailwinds with regulation, traceability, and disease-prevention trends. Management believes this market has an overall projected 6%–7% CAGR through 2030. In that context, NEOG's Petrifilm anchors future recurring consumables and end-to-end testing ecosystem.
Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves
Negative
Benzinga
1 month ago
Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination
Neogen Corporation (NASDAQ: NEOG) on Wednesday initiated a voluntary nationwide recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium Sterile Solution. The company identified microbial contamination in certain batches.
Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination
Neutral
Business Wire
1 month ago
Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.
Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution
Neutral
Seeking Alpha
1 month ago
Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Positive
Zacks Investment Research
1 month ago
Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs
NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.
Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs
Positive
The Motley Fool
1 month ago
Why Neogen Stock Blasted More Than 31% Higher Today
The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly year-over-year.
Why Neogen Stock Blasted More Than 31% Higher Today
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, Neogen (NEOG) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Neogen (NEOG) Q2 Earnings: A Look at Key Metrics
Positive
Benzinga
1 month ago
Neogen's Raised Outlook Fuels Turnaround Hopes, Stock Soars
Neogen Corp. (NASDAQ: NEOG) stock rose after the company reported better-than-expected second-quarter financial results.
Neogen's Raised Outlook Fuels Turnaround Hopes, Stock Soars
Positive
Barrons
1 month ago
Neogen Soars After Earnings Beat and Raised Outlook
Neogen beat earnings estimates, raised its full-year revenue outlook, and has now posted back-to-back post-earnings stock spikes.
Neogen Soars After Earnings Beat and Raised Outlook
Neutral
Seeking Alpha
1 month ago
Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript
Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript
Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript